8-K: HyOrc Secures $150K Convertible Note from GS Capital

HyOrc Corporation has entered into a Securities Purchase Agreement with GS Capital Partners, LLC for a $150,000 convertible promissory note, providing $139,000 in net proceeds.

Summary

• HyOrc Corporation (the "Company") entered into a Securities Purchase Agreement (SPA) with GS Capital Partners, LLC (the "Investor") on March 13, 2026.
• The Company issued a Convertible Promissory Note (the "Note") to the Investor with an original principal amount of $150,000.
• The Note includes an original issue discount of $11,000, resulting in net proceeds of $139,000 to the Company.
• Approximately $4,000 in legal and other transaction-related expenses were incurred, reducing the effective net cash to $135,000.
• The Note matures on September 13, 2026, unless converted or repaid earlier.
• The conversion price for the Note is set at 77% of the lowest trading price of the Company's common stock during the ten trading days prior to the conversion date.
• As collateral, the Company agreed to issue 250,000 shares of its common stock (Returnable Shares) to the Investor, which will be returned and cancelled upon full repayment of the Note, provided no event of default occurs.
• The Company has reserved up to 5,000,000 shares of common stock for issuance upon conversion of the Note.
• The issuance of the Note and associated shares was made under the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933 and/or Regulation D.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative development. While the capital infusion addresses immediate funding needs, the highly dilutive terms of the convertible note, including the original issue discount and the discounted conversion price, are unfavorable for existing shareholders and signal potential financial distress or limited financing options.

Positives

• The Company secured $139,000 in gross proceeds (net $135,000 after expenses), providing a capital infusion for operations.
• The financing ensures the Company has funds to continue its activities, avoiding immediate liquidity issues.

Negatives

• The Convertible Promissory Note includes an original issue discount of $11,000, meaning the Company received less cash than the principal amount.
• The conversion price is set at a significant discount (77% of the lowest trading price over 10 days), which is highly dilutive to existing shareholders.
• The issuance of 250,000 shares as collateral, even if returnable, adds complexity and potential for dispute if an event of default occurs.
• The reservation of up to 5,000,000 shares for conversion indicates a substantial potential for future dilution.

Risks

• Significant dilution risk for existing shareholders due to the discounted conversion price of 77% of the lowest trading price.
• Potential for further share price volatility as the conversion price is tied to the lowest trading price, which could incentivize downward pressure on the stock.
• Risk of default on the Note, which could lead to the Investor retaining the 250,000 collateral shares and potentially exercising other remedies.
• The Company's reliance on dilutive financing suggests challenges in securing capital on more favorable terms.

Future Outlook

The filing indicates that the Convertible Promissory Note matures on September 13, 2026, unless it is earlier converted into common stock or repaid. The Company has reserved up to 5,000,000 shares for potential conversion.

Management Comments

• The report was signed by K. Reginald Fubara, Chief Executive Officer of HyOrc Corporation, indicating management's formal acknowledgment and approval of the transaction.

Industry Context

StockSavvy.ai notes that securing convertible notes with significant discounts and original issue discounts is a common financing strategy for micro-cap or emerging growth companies, particularly those with limited access to traditional debt or equity markets. These terms often reflect a higher risk profile or a less favorable negotiating position for the issuer, as investors demand greater potential upside or protection against downside through dilutive conversion features.

Comparison to Industry Standards

• The conversion price at 77% of the lowest trading price over a 10-day period is a highly dilutive term, often seen in 'death spiral' financing arrangements for companies facing significant liquidity challenges, which is generally less favorable than standard convertible debt terms offered to more stable companies.
• The original issue discount of $11,000 on a $150,000 note (approximately 7.3%) is also a common feature in high-risk, short-term financing for companies that cannot secure capital at par.
• Compared to established companies that can access non-dilutive bank loans or equity raises at market prices, HyOrc's terms suggest a more constrained financial position, similar to other early-stage or financially distressed ventures in the market.

Stakeholder Impact

• Shareholders face significant potential dilution due to the conversion terms of the Note, which allows conversion at 77% of the lowest trading price.
• The capital raise provides necessary funding for the Company's operations, potentially benefiting employees and suppliers by ensuring continued business activity.

Next Steps

• The Company will either repay the Convertible Promissory Note by September 13, 2026, or the Note will be converted into shares of common stock by the Investor.
• The Company must ensure a sufficient number of shares are reserved for potential conversion of the Note.

Key Dates

Recommendation

The capital raise provides essential liquidity for HyOrc Corporation, which is a positive for continued operations. However, the highly dilutive terms of the convertible note, including the original issue discount and the deeply discounted conversion price, present significant downside risk for existing shareholders. Investors should hold to monitor how this capital is deployed and if the company can improve its financial position to avoid further dilutive financing, but new investment is not recommended given the unfavorable terms.

Keywords

Convertible Promissory Note, Securities Purchase Agreement, Capital Raise, Dilution, SEC 8-K, HyOrc Corporation, GS Capital Partners, Debt Financing, Equity Dilution, Emerging Growth Company